Buy ZARONTIN SYRUP 250 MG ETHOSUXIMIDE

Zarontin Syrup 250 MG is an oral medication used to manage certain types of seizures. This syrup form is designed for easy administration, particularly for those who have difficulty swallowing pills.

Strength

250 MG

Manufacturer / TM Owner

SEARCHLIGHT PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Zarontin Syrup 250 MG is primarily used for the treatment of absence seizures, a type of epileptic seizure. It works by affecting the electrical activity in the brain to prevent these seizures from occurring. Ethosuximide, the active ingredient, is often prescribed to control seizures in both children and adults. What is Zarontin Syrup used for? It is commonly used as part of a comprehensive treatment plan for managing absence seizures.

Side Effects

Common effects of Zarontin Syrup 250 MG may include drowsiness, dizziness, and stomach upset. Some individuals might experience headaches or nausea. These effects vary from person to person and are generally mild. If any of these effects persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Zarontin Syrup 250 MG should be used with caution in individuals with a history of suicidal thoughts or depression. It is important to follow the prescribed dosage and administration instructions carefully. Regular monitoring may be necessary to ensure the medication is working effectively and to manage any potential side effects.

Avoid Interactions

Zarontin Syrup 250 MG may interact with other medications, including those that affect the central nervous system. Alcohol and certain over-the-counter drugs can also interact with ethosuximide. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Zarontin Syrup is primarily used to manage absence seizures, a type of epileptic seizure.

Zarontin Syrup is taken orally, and the dosage should be determined by a healthcare provider.

Common side effects may include drowsiness, dizziness, and stomach upset.

It is important to consult a healthcare provider before taking Zarontin Syrup with other medications to avoid potential interactions.

Zarontin Syrup can be used in children, but the dosage should be determined by a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.